DYADIC INTERNATIONAL INC
DYAI · XNASCIK 1213809fmd_0GXEVJ3K2QG29W15W87NQ21HZGManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Jun 30, 2026, 35 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Cost of revenue | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 |
| Realized investment gains (losses) | – | – | – | 0 | 2 | – | 1 | 0 | – |
| Research and development | 2 | 2 | 3 | 4 | 8 | 5 | 3 | 2 | 2 |
| Operating income | (7) | (8) | (9) | (10) | (15) | (10) | (8) | (6) | (7) |
| Interest and investment income | – | – | – | – | – | – | – | 0 | 0 |
| Other non-operating income (expense) | 5 | 1 | – | 1 | 2 | 0 | 1 | 0 | (0) |
| Income before taxes | (2) | (7) | (8) | (9) | (13) | (10) | (7) | (6) | (7) |
| Income tax expense | (0) | (1) | 0 | 0 | 0 | – | – | – | – |
| Net income from continuing operations | (2) | (6) | (8) | (9) | (13) | – | – | – | – |
| Net income | (2) | (6) | (8) | (9) | (13) | (10) | (7) | (6) | (7) |